Rhea Pai
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Telomeres, Telomerase, and Senescence
Papers in
-
- DNA and Nucleic Acid Chemistry 1
- Advanced biosensing and bioanalysis techniques 1
-
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Marina K. Kukhanova (1 shared paper)S. Balakrishna Pai (1 shared paper)Yi‐Shan Cheng (1 shared paper)Ginger E. Dutschman (1 shared paper)Xiaoxiao Guo (1 shared paper)Justine Jia Wen Seow (2 shared papers)Ankur Sharma (2 shared papers)Pierce K. H. Chow (1 shared paper)
- Journals
- Frontiers in Medicine (1 paper)Journal of the Indian Institute of Science (1 paper)PubMed (1 paper)
In The Last Decade
Rhea Pai
3 papers receiving 74 citations
Peers
Comparison fields: 5 of 25
- Infectious Diseases 23
- Physiology 31
- Hepatology 7
- Neurology 12
- Biotechnology 6
Countries citing papers authored by Rhea Pai
This map shows the geographic impact of Rhea Pai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhea Pai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhea Pai more than expected).
Fields of papers citing papers by Rhea Pai
This network shows the impact of papers produced by Rhea Pai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhea Pai. The network helps show where Rhea Pai may publish in the future.
Co-authors
The 15 scholars most cited alongside Rhea Pai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Telomerase from human leukemia cells: properties and its interaction with deoxynucleoside analogues. | 1998 | 37 |
| 2 | 2021 | 31 | |
| 3 | 2020 | 8 |
About Rhea Pai
Rhea Pai is a scholar working on Molecular Biology, Infectious Diseases, Neurology, Physiology and Immunology, having authored 3 papers that have together received 76 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (1 paper), Long-Term Effects of COVID-19 (1 paper), Cancer Genomics and Diagnostics (1 paper), Telomeres, Telomerase, and Senescence (1 paper), DNA and Nucleic Acid Chemistry (1 paper), Advanced biosensing and bioanalysis techniques (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Immune cells in cancer (1 paper). The work is most often cited by research in Infectious Diseases (23 citations), Physiology (31 citations), Hepatology (7 citations), Neurology (12 citations) and Biotechnology (6 citations). Rhea Pai has collaborated with scholars based in Singapore, China and Australia. Frequent co-authors include Marina K. Kukhanova, S. Balakrishna Pai, Yi‐Shan Cheng, Ginger E. Dutschman, Xiaoxiao Guo, Justine Jia Wen Seow, Ankur Sharma, Pierce K. H. Chow, Tony Kiat Hon Lim and Florent Ginhoux. Their work appears in journals such as Frontiers in Medicine, Journal of the Indian Institute of Science and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.